Trevena Appoints Barry Shin as Chief Financial Officer

Jun 27, 2019 7:00am EDT

Trevena Announces Publication of APOLLO-2 Results in Pain Practice

Jun 24, 2019 7:00am EDT

Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine

Jun 20, 2019 7:00am EDT

Trevena to Participate in Upcoming Conferences in June 2019

May 29, 2019 4:01pm EDT

Trevena Reports First Quarter 2019 Results

May 10, 2019 7:00am EDT

Trevena Reports Fourth Quarter and Full Year 2018 Results

Mar 13, 2019 7:00am EDT

Trevena Announces Publication of APOLLO-1 Results in The Journal of Pain Research Highlighting Oliceridine’s Potential for Management of Moderate-to-Severe Acute Pain

Mar 11, 2019 3:00am EDT

Trevena to Report Fourth Quarter and Full Year 2018 Results on March 13, 2019

Mar 04, 2019 7:00am EST

Trevena to Present at the 21st Annual BIO CEO & Investor Conference

Feb 05, 2019 6:58pm EST

Trevena Announces $10 Million Registered Direct Offering of Common Stock

Jan 30, 2019 7:00am EST